Gestational Diabetes NCLEX Questions With Rationales
What it is
Gestational diabetes mellitus (GDM) is glucose intolerance first recognized during pregnancy that does not meet the criteria for overt diabetes identified before or during early pregnancy. Pregnancy hormones increase insulin resistance, making it more difficult for some individuals to maintain normal blood glucose levels. Uncontrolled hyperglycemia increases maternal and fetal complications, making glucose monitoring, nutrition management, physical activity, and appropriate medication essential.
What the NCLEX focuses on
- Screen for gestational diabetes between 24 and 28 weeks of gestation when diabetes has not already been diagnosed earlier in pregnancy.
- Individuals with risk factors for diabetes may require testing earlier in pregnancy to identify previously unrecognized diabetes.
- The one-step screening approach uses a fasting 75-g oral glucose tolerance test, and any one abnormal result establishes the diagnosis.
- One-step diagnostic thresholds are fasting glucose of 92 mg/dL, 1-hour glucose of 180 mg/dL, and 2-hour glucose of 153 mg/dL.
- The two-step approach begins with a nonfasting 50-g glucose challenge test, followed by a fasting 100-g oral glucose tolerance test when the screening result meets the laboratory's selected threshold.
- Using Carpenter-Coustan criteria, at least two abnormal values on the 100-g test generally establish GDM, although ACOG recognizes that one elevated value may also be used for diagnosis.
- For individuals with GDM not treated with insulin, commonly used glucose targets are fasting below 95 mg/dL, 1-hour postmeal below 140 mg/dL, or 2-hour postmeal below 120 mg/dL.
- Medical nutrition therapy, individualized carbohydrate distribution, regular meals, and appropriate physical activity are initial management strategies.
- Insulin is the preferred medication when lifestyle measures do not achieve glucose targets because it does not cross the placenta in clinically significant amounts.
Priority nursing actions
- Assess maternal risk factors, screening history, glucose results, nutritional intake, and understanding of gestational diabetes.
- Teach proper blood glucose monitoring and documentation of fasting and postmeal values as prescribed.
- Reinforce individualized nutrition planning, consistent carbohydrate intake, and appropriate physical activity, such as walking after meals when medically permitted.
- Administer prescribed insulin, monitor glucose response, and assess for hypoglycemia, including sweating, tremors, hunger, dizziness, and confusion.
- Monitor fetal growth and maternal status as ordered because uncontrolled hyperglycemia increases the risk of macrosomia, birth complications, and hypertensive disorders.
- After delivery, coordinate postpartum glucose testing and reinforce long-term diabetes prevention and screening.
Numbers to know
| Value | Number | Why it matters |
|---|---|---|
| Routine screening | 24 to 28 weeks | Recommended screening period when GDM has not been diagnosed earlier. |
| One-step 75-g OGTT, fasting | 92 mg/dL or higher | Meets the diagnostic threshold. |
| One-step 75-g OGTT, 1 hour | 180 mg/dL or higher | Meets the diagnostic threshold. |
| One-step 75-g OGTT, 2 hours | 153 mg/dL or higher | Meets the diagnostic threshold. |
| Pregnancy fasting glucose target | Below 95 mg/dL | Common treatment target. |
| Postmeal glucose targets | Below 140 mg/dL at 1 hour, or below 120 mg/dL at 2 hours | Helps guide glucose management. |
| Postpartum screening | 4 to 12 weeks | A 75-g OGTT assesses persistent glucose intolerance. |
Common exam traps
- Choosing a 50-g glucose challenge test as a fasting diagnostic test: wrong because the initial 50-g screening test is nonfasting.
- Choosing the one-step diagnosis after requiring two abnormal values: wrong because only one abnormal value is required with the 75-g one-step criteria.
- Choosing oral medication as the preferred initial pharmacologic treatment: wrong because insulin is the preferred medication when nutrition and physical activity do not achieve glucose targets.
- Choosing to discontinue all glucose monitoring after delivery without follow-up: wrong because persistent diabetes or prediabetes may be identified postpartum.
- Choosing to use A1C instead of the recommended postpartum OGTT at the initial follow-up: wrong because the 75-g OGTT is preferred at 4 to 12 weeks postpartum.
What to teach
- Eat balanced meals at regular intervals and follow the individualized meal plan provided by the diabetes care team.
- Monitor fasting and postmeal blood glucose as instructed and bring the glucose record to prenatal appointments.
- Perform appropriate physical activity regularly, unless the obstetric provider identifies a contraindication.
- Recognize hypoglycemia and follow the prescribed treatment plan if symptoms or low glucose readings occur.
- Understand that maternal hyperglycemia can cause fetal macrosomia, birth trauma, neonatal hypoglycemia, respiratory problems, and increased risk of hypertensive disorders.
- Complete the 75-g postpartum OGTT and continue lifelong diabetes screening every 1 to 3 years because previous GDM increases future risk of type 2 diabetes.
2 NCLEX questions with rationales on this topic
From the NCLEXPace question bank. Choose your answer first, then open the correct answer and the full rationale under each question.
A client whose gestational diabetes was controlled with diet is being discharged 2 days after birth. Which statement indicates that she understands the follow-up plan?
Select the best answer.
- A. "I need a glucose tolerance test 4 to 12 weeks after delivery."
- B. "I should use formula, because breastfeeding makes my glucose harder to control."
- C. "I will check my glucose before meals and at bedtime every day from now on."
- D. "The diabetes ended with the placenta, so I need no more glucose testing."
Show the correct answer and rationale
Correct answer:
- A. "I need a glucose tolerance test 4 to 12 weeks after delivery."
Rationale
Overview
- Definition: Gestational diabetes is hyperglycemia first recognized during pregnancy. Glucose levels usually improve after placental delivery, but a history of gestational diabetes increases future type 2 diabetes risk.
- Follow-up plan: Perform a fasting 75-g, two-hour oral glucose tolerance test at 4 to 12 weeks postpartum. Continue diabetes screening every 1 to 3 years, even after a normal result.
- Prevention: Breastfeeding, physical activity, healthy nutrition, and weight management reduce long-term metabolic risk.
Nursing key points
- Schedule the 75-g, two-hour oral glucose tolerance test at 4 to 12 weeks postpartum.
- Explain that normal postpartum glucose results do not eliminate future diabetes risk.
- Arrange lifelong screening for diabetes or prediabetes every 1 to 3 years.
- Encourage breastfeeding and regular physical activity.
- Provide nutrition, weight-management, and preconception counseling before another pregnancy.
Answer analysis
| Client statement | Rationale |
|---|---|
| "I need a glucose tolerance test 4 to 12 weeks after delivery." | Correct understanding. Postpartum testing identifies persistent diabetes or prediabetes. |
| "I should use formula, because breastfeeding makes my glucose harder to control." | Needs further teaching. Breastfeeding is encouraged and reduces long-term maternal diabetes risk. |
| "I will check my glucose before meals and at bedtime every day from now on." | Needs further teaching. Permanent frequent home testing is not routine after resolved gestational diabetes. |
| "The diabetes ended with the placenta, so I need no more glucose testing." | Needs further teaching. Persistent glucose abnormalities and future type 2 diabetes require follow-up testing. |
The nurse teaches a client newly diagnosed with gestational diabetes at 27 weeks about the risks to her baby. For each complication, indicate whether it is an expected risk of gestational diabetes or is not attributable to gestational diabetes.
| Expected risk of gestational diabetes | Not attributable to gestational diabetes | |
|---|---|---|
| Hypoglycemia in the first hours after birth | ||
| Congenital heart defect | ||
| Macrosomia with shoulder dystocia at birth | ||
| Neural tube defect | ||
| Neonatal hyperbilirubinemia |
Show the correct answer and rationale
Correct answers:
- Hypoglycemia in the first hours after birth: Expected risk of gestational diabetes
- Congenital heart defect: Not attributable to gestational diabetes
- Macrosomia with shoulder dystocia at birth: Expected risk of gestational diabetes
- Neural tube defect: Not attributable to gestational diabetes
- Neonatal hyperbilirubinemia: Expected risk of gestational diabetes
Rationale
Overview
- Definition: Gestational diabetes is hyperglycemia first recognized during pregnancy. Hyperglycemia that begins after organogenesis produces fetal growth and neonatal metabolic complications rather than structural congenital defects.
- Fetal risks: Maternal glucose crosses the placenta and stimulates fetal insulin secretion. Fetal hyperinsulinemia increases macrosomia and shoulder dystocia risk.
- Newborn risks: Persistent neonatal hyperinsulinemia causes early hypoglycemia. Increased erythrocyte production and breakdown contribute to hyperbilirubinemia.
Nursing key points
- Explain that fetal hyperinsulinemia promotes birth weight above 4,000 to 4,500 g and increases shoulder dystocia risk.
- Monitor maternal glucose and reinforce the prescribed nutrition and treatment plan.
- Prepare for neonatal glucose screening during the first hours after birth.
- Assess the newborn for jitteriness, poor feeding, lethargy, and other signs of hypoglycemia.
- Monitor bilirubin levels and assess for jaundice according to newborn protocols.
Answer analysis
| Complication | Expected risk of gestational diabetes? | Why |
|---|---|---|
| Hypoglycemia in the first hours after birth | Expected risk of gestational diabetes. | Persistent neonatal insulin secretion lowers glucose after delivery. |
| Congenital heart defect | Not attributable to gestational diabetes. | Cardiac defects are associated with hyperglycemia during early cardiac development. |
| Macrosomia with shoulder dystocia at birth | Expected risk of gestational diabetes. | Excess fetal insulin promotes adipose tissue growth and increases delivery complications. |
| Neural tube defect | Not attributable to gestational diabetes. | Neural tube defects arise during early organogenesis and are associated with preexisting or early-pregnancy hyperglycemia. |
| Neonatal hyperbilirubinemia | Expected risk of gestational diabetes. | Increased erythrocyte turnover raises bilirubin production. |
The NCLEXPace bank has 3,200+ NCLEX questions with full rationales, sorted by topic, with your progress tracked as you practice. Create your account to start.
Create Account →More topics in Maternal & Newborn
Labor Induction and Oxytocin NCLEX Questions With RationalesReviews induction indications, Bishop scoring, cervical ripening, oxytocin administration, tachysystole, fetal monitoring, and amniotomy care.Congenital Hypothyroidism NCLEX Questions With RationalesReviews newborn screening, early treatment, clinical findings, levothyroxine administration, laboratory monitoring, and parent education.Neonatal Sepsis NCLEX Questions With RationalesCovers neonatal sepsis onset, maternal and newborn risk factors, clinical findings, diagnosis, antibiotic treatment, and nursing priorities.Sources
- American Diabetes Association. Diagnosis and Classification of Diabetes: Standards of Care in Diabetes, 2026. 2026.
- American Diabetes Association. Management of Diabetes in Pregnancy: Standards of Care in Diabetes, 2026. 2026.
- American College of Obstetricians and Gynecologists. Gestational Diabetes. Current edition.
- American Diabetes Association. Diabetes and Pregnancy. Current guidance.
3,200+ NCLEX questions with think-like-a-nurse rationales, unfolding case studies and adaptive readiness exams. Start with free practice questions, then choose a plan when you are ready.
Create Account →